YM17E

Known as: YM 17E 
 

Topic mentions per year

Topic mentions per year

1993-1998
01219931998

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
The relationship between bioavailability and the serum cholesterol-lowering effect of YM17E, an ACAT inhibitor was investigated… (More)
Is this relevant?
1997
1997
YM17E (1,3-bis[[1-cycloheptyl-3-(p-dimethylaminophenyl)ureido]methyl]ben zene dihydrochloride) was found to be a potent inhibitor… (More)
Is this relevant?
1997
1997
We conducted a single and repeat oral dose study of YM17E, a novel inhibitor of acyl coenzyme A (CoA): cholesterol… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
1996
1996
Because YM17E (1,3-bis[[1-cycloheptyl-3-(p-dimethylaminophenyl) ureido]methyl]benzene dihydrochloride) inhibits acyl coenzyme A… (More)
Is this relevant?
1994
1994
1. We have investigated the disposition and metabolism of YM17E after intravenous and oral administration in the rat and dog. 2… (More)
Is this relevant?
1993
1993
We describe a reversed-phase high-performance liquid chromatographic method for the determination in plasma of YM17E (I), an… (More)
Is this relevant?
1993
1993
The metabolism of 1,3-bis[[1-cycloheptyl-3-(p-dimethylamino- phenyl)ureido]methyl]benzene dihydrochloride (YM17E) in rat liver… (More)
Is this relevant?